China Animal Healthcare, one of the leading players in China’s animal drugs industry, says net profit increased 40.5% to net profit to RMB48.5 million ($10.1 million) from RMB34.5 million.
Revenue rose 36.2% to RMB132.5 million since it established its own production facilities in Shenzhou in October 1997 to commence in-house production of its products.
The return to growth in sales of powdered form drugs continued to gain momentum in 4Q2009 with revenue topping RMB106.9 million, an increase of 44.5% over 4Q2008. Sales for this segment in 4Q2008 was saddled by the bird flu scare.
